PHARMACODYNAMICS OF AMOXICILLIN IN VITRO AND EX VIVO AGAINST CALF RESPIRATORY PATHOGENS
Presentation / Conference Contribution
Illambas, J., Potter, T., Rycroft, A. N., & Lees, P. PHARMACODYNAMICS OF AMOXICILLIN IN VITRO AND EX VIVO AGAINST CALF RESPIRATORY PATHOGENS
All Outputs (120)
PHARMACODYNAMICS OF TULATHROMYCIN IN VITRO AND EX VIVO AGAINST CALF PATHOGENS
Presentation / Conference Contribution
Illambas, J., Potter, T., Rycroft, A. N., & Lees, P. PHARMACODYNAMICS OF TULATHROMYCIN IN VITRO AND EX VIVO AGAINST CALF PATHOGENS
Analytical determination and pharmacokinetics of robenacoxib in the dog
Journal Article
Jung, M., Lees, P., Seewald, W., & King, J. N. Analytical determination and pharmacokinetics of robenacoxib in the dog. Journal of Veterinary Pharmacology and Therapeutics, 32(1), 41-48. https://doi.org/10.1111/j.1365-2885.2008.01035.x
Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2
Journal Article
King, J. N., Dawson, J., Esser, R. E., Fujimoto, R., Kimble, E. F., Maniara, W., Marshall, P. J., O'Byrne, L., Quadros, E., Toutain, P. L., & Lees, P. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2. Journal of Veterinary Pharmacology and Therapeutics, 32(1), 1-17. https://doi.org/10.1111/j.1365-2885.2008.00962.x
Evaluation of robenacoxib as a cyclooxygenase inhibitor in the dog: a comparative study
Journal Article
King, J. N., Rudaz, C., Borer, L., Jung, M., Seewald, W., & Lees, P. Evaluation of robenacoxib as a cyclooxygenase inhibitor in the dog: a comparative study. Journal of Veterinary Pharmacology and Therapeutics, 32, 222-222
PHARMACOKINETICS AND PHARMACODYNAMICS OF MAVACOXIB IN THE DOG
Presentation / Conference Contribution
Lees, P., Alexander-Bowman, S., Hummel, B., Kubiak, T., Michels, G., Krautmann, M., Cox, S., Toutain, P. L., & Stegemann, M. PHARMACOKINETICS AND PHARMACODYNAMICS OF MAVACOXIB IN THE DOG
PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
Presentation / Conference Contribution
Lees, P., Giraudel, J., Toutain, P. L., Pelligand, L., & King, J. N. PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
Presentation / Conference Contribution
Pelligand, L., King, J. N., Toutain, P. L., & Lees, P. IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
INTEGRATION AND MODELLING OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR OXYTETRACYCLINE IN CALVES
Presentation / Conference Contribution
Potter, T. J., Illambas, J., Rycroft, A. N., Brentnall, C., McKellar, Q. A., & Lees, P. INTEGRATION AND MODELLING OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR OXYTETRACYCLINE IN CALVES
INTEGRATION AND MODELLING OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR MARBOFLOXACIN IN CALVES
Presentation / Conference Contribution
Potter, T. J., Illambas, J., Rycroft, A. N., & Lees, P. INTEGRATION AND MODELLING OF PHARMACOKINETIC AND PHARMACODYNAMIC DATA FOR MARBOFLOXACIN IN CALVES
IN VITRO AND EX VIVO INHIBITION OF COX ISOFORMS BY ROBENACOXIB IN THE CAT: A COMPARATIVE STUDY
Presentation / Conference Contribution
Schmid, V. B., King, J. N., Seewald, W., & Lees, P. IN VITRO AND EX VIVO INHIBITION OF COX ISOFORMS BY ROBENACOXIB IN THE CAT: A COMPARATIVE STUDY
ANALGESIC AND ANTI-INFLAMMATORY ACTIONS OF ROBENACOXIB IN ACUTE JOINT INFLAMMATION IN THE DOG
Presentation / Conference Contribution
Schmid, V. B., Spreng, D. E., Seewald, W., Jung, M., Lees, P., & King, J. N. ANALGESIC AND ANTI-INFLAMMATORY ACTIONS OF ROBENACOXIB IN ACUTE JOINT INFLAMMATION IN THE DOG
PHARMACOKINETICS AND PHARMACODYNAMICS OF FLORFENICOL IN CALVES
Presentation / Conference Contribution
Sidhu, P. K., Illambas, J., Potter, T. J., Rycroft, A. N., & Lees, P. PHARMACOKINETICS AND PHARMACODYNAMICS OF FLORFENICOL IN CALVES
PK-PD MODELLING OF MARBOFLOXACIN IN THE PRESENCE AND ABSENCE OF TOLFENAMIC ACID IN TWO RUMINANT SPECIES
Presentation / Conference Contribution
Sidhu, P. K., Toutain, P. L., Aliabadi, F. S., Landoni, M. F., & Lees, P. PK-PD MODELLING OF MARBOFLOXACIN IN THE PRESENCE AND ABSENCE OF TOLFENAMIC ACID IN TWO RUMINANT SPECIES
Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors
Journal Article
Rickards, K. J., Page, C. P., Lees, P., & Cunningham, F. M. Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors. Journal of Veterinary Pharmacology and Therapeutics, 24(4), 275-281. https://doi.org/10.1046/j.1365-2885.2001.00344.x
In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood
Journal Article
Rickards, K. J., Page, C. P., Lees, P., Gettinby, G., & Cunningham, F. M. In vitro and ex vivo effects of the phosphodiesterase 4 inhibitor, rolipram, on thromboxane production in equine blood. Journal of Veterinary Pharmacology and Therapeutics, 26(2), 123-130. https://doi.org/10.1046/j.1365-2885.2003.00450.x
Tissue chamber model of acute inflammation in farm animal species
Journal Article
Sidhu, P., Aliabadi, F. S., Andrews, M., & Lees, P. Tissue chamber model of acute inflammation in farm animal species. Research in Veterinary Science, 74(1), 67-77
Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration
Journal Article
Aliabadi, F. S., & Lees, P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research, 62(12), 1979-1989. https://doi.org/10.2460/ajvr.2001.62.1979
Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep
Journal Article
Arifah, A. K., Landoni, M. F., Frean, S. P., & Lees, P. Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep. American Journal of Veterinary Research, 62(1), 77-86. https://doi.org/10.2460/ajvr.2001.62.77
Veterinary homeopathy regulation in the UK – a cause for concern
Journal Article
Whitehead, M. L., Lees, P., & Toutain, P. L. Veterinary homeopathy regulation in the UK – a cause for concernPractitioners of homeopathy claim to treat illness by
manipulation of an undetectable healing force or energy. The Veterinary Medicines Regulations 2013 allow homeopathic products to be registered without proof of therapeutic efficacy, as required b... Read More about Veterinary homeopathy regulation in the UK – a cause for concern.